ImmunoGen Current Ratio 2006-2018 | IMGN

ImmunoGen current ratio from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
ImmunoGen Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-12-31 $0.28B $0.07B 3.95
2018-09-30 $0.32B $0.07B 4.59
2018-06-30 $0.37B $0.06B 5.76
2018-03-31 $0.25B $0.07B 3.74
2017-12-31 $0.28B $0.06B 4.96
2017-09-30 $0.21B $0.07B 2.81
2017-06-30 $0.16B $0.07B 2.40
2017-03-31 $0.14B $0.04B 3.52
2016-12-31 $0.18B $0.06B 3.16
2016-09-30 $0.21B $0.06B 3.69
2016-06-30 $0.25B $0.06B 4.19
2016-03-31 $0.19B $0.04B 4.85
2015-12-31 $0.22B $0.04B 5.09
2015-09-30 $0.26B $0.04B 7.29
2015-06-30 $0.29B $0.04B 8.16
2015-03-31 $0.12B $0.02B 5.22
2014-12-31 $0.11B $0.02B 5.82
2014-09-30 $0.13B $0.04B 3.23
2014-06-30 $0.15B $0.02B 7.09
2014-03-31 $0.17B $0.02B 8.13
2013-12-31 $0.19B $0.02B 10.75
2013-09-30 $0.19B $0.02B 11.35
2013-06-30 $0.20B $0.02B 10.47
2013-03-31 $0.22B $0.02B 12.83
2012-12-31 $0.22B $0.02B 14.84
2012-09-30 $0.24B $0.02B 15.48
2012-06-30 $0.17B $0.02B 10.23
2012-03-31 $0.18B $0.02B 12.29
2011-12-31 $0.19B $0.01B 16.66
2011-09-30 $0.18B $0.01B 13.89
2011-06-30 $0.20B $0.02B 13.84
2011-03-31 $0.13B $0.01B 9.36
2010-12-31 $0.14B $0.01B 12.66
2010-09-30 $0.10B $0.01B 10.53
2010-06-30 $0.12B $0.01B 8.47
2010-03-31 $0.05B $0.01B 4.22
2009-12-31 $0.06B $0.01B 5.06
2009-09-30 $0.07B $0.01B 6.63
2009-06-30 $0.08B $0.01B 6.91
2009-03-31 $0.05B $0.01B 4.11
2008-12-31 $0.05B $0.01B 4.07
2008-09-30 $0.05B $0.01B 5.10
2008-06-30 $0.06B $0.01B 5.40
2008-03-31 $0.05B $0.02B 2.53
2007-12-31 $0.06B $0.01B 4.44
2007-09-30 $0.07B $0.01B 5.24
2007-06-30 $0.07B $0.01B 5.05
2007-03-31 $0.08B $0.01B 5.30
2006-12-31 $0.08B $0.01B 6.13
2006-09-30 $0.08B $0.01B 6.53
2006-06-30 $0.09B $0.01B 7.88
2006-03-31 $0.09B $0.01B 7.39
2005-12-31 $0.09B $0.01B 8.61
2005-09-30 $0.10B $0.01B 10.20
2005-06-30 $0.10B $0.01B 10.83
2005-03-31 $0.10B $0.01B 9.13
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.378B $0.054B
ImmunoGen, Inc. develops pharmaceuticals, primarily for the treatment of cancer. The company's product candidates are called tumor-activated prodrugs and are based on its proprietary immunoconjugate technology platform. Unlike conventional chemotherapeutic agents, tumor-activated prodrugs are intended to deliver potent chemotherapy specifically to a tumor. Each tumor-activated drug immunoconjugate comprises a small-molecule drug which has been chemically linked to a monoclonal antibody.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $47.264B 31.44
Takeda Pharmaceutical (TAK) Japan $33.216B 12.29
Grifols (GRFS) Spain $13.242B 16.05
Ionis Pharmaceuticals (IONS) United States $11.018B 34.17
Neurocrine Biosciences (NBIX) United States $7.958B 515.41
Jazz Pharmaceuticals (JAZZ) Ireland $7.734B 11.07
Sage Therapeutics (SAGE) United States $7.351B 0.00
Tilray (TLRY) United States $6.502B 0.00
Catalent (CTLT) United States $6.214B 26.02
Nektar Therapeutics (NKTR) United States $5.991B 9.56
United Therapeutics (UTHR) United States $5.188B 8.82
FibroGen (FGEN) United States $4.806B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.304B 22.87
Taro Pharmaceutical Industries (TARO) Israel $4.234B 13.63
Portola Pharmaceuticals (PTLA) United States $2.233B 0.00
Zogenix (ZGNX) United States $2.222B 0.00
Madrigal Pharmaceuticals (MDGL) United States $2.218B 0.00
PTC Therapeutics (PTCT) United States $2.176B 0.00
USANA Health Sciences (USNA) United States $2.131B 17.89
Ironwood Pharmaceuticals (IRWD) United States $2.108B 0.00
Aerie Pharmaceuticals (AERI) United States $2.075B 0.00
Enanta Pharmaceuticals (ENTA) United States $2.017B 25.13
Endo (ENDP) Ireland $1.968B 3.03
Heron Therapeutics (HRTX) United States $1.924B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.774B 0.00
Xencor (XNCR) United States $1.704B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.681B 145.64
Corcept Therapeutics (CORT) United States $1.401B 20.35
TherapeuticsMD (TXMD) United States $1.336B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.334B 0.00
Esperion Therapeutics (ESPR) United States $1.179B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.122B 0.00
Tricida (TCDA) United States $1.077B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.869B 0.00
Radius Health (RDUS) United States $0.854B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.609B 0.00
Dermira (DERM) United States $0.598B 0.00
Odonate Therapeutics (ODT) United States $0.589B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.587B 0.00
Collegium Pharmaceutical (COLL) United States $0.579B 0.00
ChemoCentryx (CCXI) United States $0.577B 0.00
Forty Seven (FTSV) United States $0.571B 0.00
GlycoMimetics (GLYC) United States $0.546B 0.00
ArQule (ARQL) United States $0.524B 0.00
KalVista Pharmaceuticals (KALV) United States $0.487B 0.00
Siga Technologies (SIGA) United States $0.486B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.485B 28.62
Corbus Pharmaceuticals Holdings (CRBP) United States $0.481B 0.00
Akebia Therapeutics (AKBA) United States $0.462B 0.00
Flexion Therapeutics (FLXN) United States $0.462B 0.00
Translate Bio (TBIO) United States $0.453B 0.00
TCR2 THERAPTCS (TCRR) United States $0.439B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.428B 0.00
Concert Pharmaceuticals (CNCE) United States $0.394B 0.00
OptiNose (OPTN) United States $0.388B 0.00
Aptorum Group (APM) China $0.378B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.358B 0.00
Minerva Neurosciences (NERV) United States $0.329B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.329B 0.00
Karyopharm Therapeutics (KPTI) United States $0.326B 0.00
Lannett Co Inc (LCI) United States $0.317B 2.94
CASI Pharmaceuticals (CASI) United States $0.315B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.303B 11.24
HARPOON THERAPT (HARP) United States $0.290B 0.00
Aclaris Therapeutics (ACRS) United States $0.285B 0.00
Mast Therapeutics (SVRA) United States $0.284B 0.00
Immune Design (IMDZ) United States $0.283B 0.00
Xeris Pharmaceuticals (XERS) United States $0.282B 0.00
Majesco Entertainment (PTE) United States $0.271B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.269B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.263B 0.00
Affimed (AFMD) Germany $0.261B 0.00
Dova Pharmaceuticals (DOVA) United States $0.261B 0.00
Calithera Biosciences (CALA) United States $0.252B 0.00
ElectroCore (ECOR) United States $0.237B 0.00
Opexa Therapeutics (ACER) United States $0.237B 0.00
Tyme Technologies (TYME) United States $0.237B 0.00
Galectin Therapeutics (GALT) United States $0.228B 0.00
Jounce Therapeutics (JNCE) United States $0.226B 0.00
Aldeyra Therapeutics (ALDX) United States $0.219B 0.00
MEI Pharma (MEIP) United States $0.218B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.207B 0.00
Ardelyx (ARDX) United States $0.205B 0.00
IMV INC (IMV) Canada $0.204B 0.00
Molecular Templates (MTEM) United States $0.202B 0.00
Recro Pharma (REPH) United States $0.200B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.200B 0.00
Nature's Sunshine Products (NATR) United States $0.195B 202.00
Aratana Therapeutics (PETX) United States $0.191B 0.00
Redhill Biopharma (RDHL) Israel $0.187B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.184B 0.00
Rafael Holdings (RFL) United States $0.176B 0.00
Ocular Therapeutix (OCUL) United States $0.176B 0.00
Aquestive Therapeutics (AQST) United States $0.174B 0.00
Neon Therapeutics (NTGN) United States $0.167B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.160B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.158B 0.00
China SXT Pharmaceuticals (SXTC) China $0.144B 0.00
ProNAi Therapeutics (SRRA) Canada $0.143B 0.00
AgeX Therapeutics (AGE) United States $0.142B 0.00
Cardiome Pharma (CORV) Canada $0.142B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.141B 0.00
MediWound (MDWD) Israel $0.141B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.140B 0.00
Champions Oncology (CSBR) United States $0.129B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.128B 0.00
DURECT (DRRX) United States $0.121B 0.00
Zafgen (ZFGN) United States $0.111B 0.00
Adherex Technologies (FENC) United States $0.110B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.109B 0.00
Infinity Pharmaceuticals (INFI) United States $0.102B 0.00
Iterum Therapeutics (ITRM) Ireland $0.096B 0.00
Nivalis Therapeutics (ALPN) United States $0.095B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.092B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.091B 0.00
Otonomy (OTIC) United States $0.091B 0.00
SCYNEXIS (SCYX) United States $0.087B 0.00
Neos Therapeutics (NEOS) United States $0.087B 0.00
India Globalization Capital (IGC) United States $0.086B 0.00
Natural Alternatives (NAII) United States $0.084B 8.20
Genocea Biosciences (GNCA) United States $0.081B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.074B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.073B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.069B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.067B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.061B 0.00
Avenue Therapeutics (ATXI) United States $0.059B 0.00
CTI BioPharma (CTIC) United States $0.059B 0.00
Forward Pharma (FWP) Denmark $0.058B 0.00
KemPharm (KMPH) United States $0.056B 0.00
Melinta Therapeutics (MLNT) United States $0.053B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.052B 0.00
Lipocine (LPCN) United States $0.052B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.050B 0.00
Capnia (SLNO) United States $0.049B 0.00
BioLineRx (BLRX) Israel $0.047B 0.00
Mannatechorporated (MTEX) United States $0.042B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.040B 0.00
ProPhase Labs (PRPH) United States $0.039B 0.00
NOVAN INC (NOVN) United States $0.034B 0.00
HANCOCK JAFFE (HJLI) United States $0.034B 0.00
Achaogen (AKAO) United States $0.033B 0.00
PharmAthene (ALT) United States $0.030B 0.00
Heat Biologics (HTBX) United States $0.030B 0.00
ContraFect (CFRX) United States $0.029B 0.00
Shineco (TYHT) China $0.028B 4.69
Summit Therapeutics (SMMT) United Kingdom $0.027B 0.00
Citius Pharmaceuticals (CTXR) United States $0.027B 0.00
IsoRay (ISR) United States $0.025B 0.00
Can-Fite Biopharma (CANF) Israel $0.025B 0.00
Onconova Therapeutics (ONTX) United States $0.024B 0.00
Biomerica (BMRA) United States $0.023B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.023B 0.00
Jaguar Animal Health (JAGX) United States $0.023B 0.00
ESSA Pharma (EPIX) Canada $0.022B 0.00
Pain Therapeutics (PTIE) United States $0.022B 0.00
Achieve Life Sciences (ACHV) United States $0.021B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.020B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.019B 0.00
NanoViricides (NNVC) United States $0.019B 0.00
Xenetic Biosciences (XBIO) United States $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
Bio-Path Holdings (BPTH) United States $0.017B 0.00
VAXART, INC (VXRT) United States $0.017B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.012B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.012B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.012B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.011B 0.00
Midatech Pharma (MTP) United Kingdom $0.011B 0.00
Regulus Therapeutics (RGLS) United States $0.010B 0.00
Trillium Therapeutics (TRIL) Canada $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.008B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.007B 0.00
Intellipharmaceutics (IPCI) Canada $0.006B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.006B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.004B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.000B 0.00
Bio Blast Pharma (ORPN) Israel $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00